Events

Loading Events

« All Events

FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop

August 21 - August 22

The Food and Drug Administration is holding a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections.” The purpose of the public workshop is to discuss the general development considerations of non-traditional therapies, including pre-clinical development, early clinical studies, and phase 3 clinical trial designs to evaluate safety and efficacy.

Presentations by Kevin Outterson, Executive Director of CARB-X, and John Rex, Chief Medical Officer of F2G Ltd.

Details

Start:
August 21
End:
August 22
Website:
https://www.fda.gov/Drugs/NewsEvents/ucm606052.htm

Organizer

FDA

Venue

FDA White Oak Campus – Building 31
10903 New Hampshire Ave
Silver Spring, MD 20993 United States
+ Google Map